School-based deworming Challenges Collaborations Commitment
Feb 09, 2016
School-based deworming
ChallengesCollaborationsCommitment
School based deworming
Age (years)
Mea
n no
of w
orm
s
Age-infection profile for STH infections
Benefits of deworming
Long term increases in
productivity over a life time
School Adulthood
Treat at least 75% of at risk children by 2010By 2010, only 1/3 of children requiring treatment were
receiving it.
Improved attendance
Improved performance
Challenges to deworming• Commitment & ownership• Coordination• Resources
– Human– Financial– Antihelminthics
• Accurate reporting • Uptake• Evidence
Sustain, expand and extend drug access programmes to ensure the necessary
supply of drugs and other interventions to help control by 2020 schistosomiasis,
STH, Chagas disease, VL, and onchocerciasis.
Enhance collaboration and coordination on NTDs at national and international levels
through public and private multilateral organisations to work more efficiently and
effectively together
Since 2012, we have seen in an increase in the level of commitment towards controlling STH infections
Sustain, expand and extend drug access programmes to ensure the necessary
supply of drugs and other interventions to help control by 2020 schistosomiasis,
STH, Chagas disease, VL, and onchocerciasis.
Enhance collaboration and coordination on NTDs at national and international levels
through public and private multilateral organisations to work more efficiently and
effectively together
Since 2012, we have seen in an increase in the level of commitment towards controlling STH infections
This Commitment was reiterated and
reinforced at the NTD meeting in Paris in April
Staying Vigilant
2008 2009 2010 2011 201202468
101214
Children dewormed through SF programmes
mill
ions- Change in procurement
- Issues in reporting structure: drugs consumed or drugs delivered?
- Lack of communication between stakeholders at all levels
Numbers being reached through WFP dropped between 2008 and 2012.
Breaks in the supply chain:
Working together to identify the gaps, ensuring intervention sustainability
But… the Pieces are in Place• Strong evidence base• Global advocacy• Donations: 1.12 billion treatments are being donated:
– GSK – 400m tablets of albendazole a year – J&J – 200m tablets of mebendazole– Merck – 250m tablets of PZQ a year
• Commitments from organisations for delivery, research, integration strategies
• Commitments from governments • Serves as the largest coordinated effort to date to
combat NTDs
Linking research with the fieldElimination of Ascaris – what is the breakpoint?
Anderson R et al. Phil. Trans. R. Soc. B 2014
Developing risk maps from prevalence data to inform intervention and MDA programmes
Harnessing existing capacity• Integrate with other activities:
– Other NTD control programmes (eg oncho)– Other delivery mechanisms– Maximise resources
The reach of the WFP
Role of Partnerships
Community, Schools & Teachers
GovernmentNGOs
Donors
International organizations
Challenges do Remain:• Continued commitment• Delivering drugs to those who need them• Coordinating players• Measuring Progress: is it pills consumed
or pills delivered?• Increasing coverage
– Reaching SAC not enrolled and pre-SAC• Sustainability
It is possible….
The case of Bihar state, India
• Included coordination between all partners, mapping, cascaded trainings, community sensitization, monitoring
• Programme implemented from Feb –April 2011• Treated >17 million school-age children for 30
cents/child
PCD
• Implementing evidence based research• Collaborate with:
– Governments– Other NGOs– Academia
• Supporters rather than implementers• Working in Partnership
Find out more @
www.child-development.org
For our latest• Research• Case studies• Toolkitsand views
www.facebook.com/PartnershipforChildDevelopment
@ schoolhealth
Find out more @
www.schoolsandhealth.org
Follow SHN @schoolhealth
For School Health & Nutrition (SHN): • Documents & resources • News & Events• SHN topic information• Country specific data